← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Sqz Biotechnologies Company, Inc.
Watertown, MA
$5,344,630
Total funding
7
Grants
Funding over time
peak $1.6M · FY2015–22$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,344,630 · 7
By mechanism
R44$4,124,540 · 3
R43$1,220,090 · 4
Investigators at Sqz Biotechnologies Company, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
Microfluidic cell squeezing platform for the transdifferentiation of somatic cells for efficient generation of a cell replacement therapy for Parkinsons Disease$1,001,356
R44 · FY2022 · GM
A Vector-free Intracellular Delivery Platform for Drug Discovery$807,544
R44 · FY2017 · GM
Applications of a robust, vector-free intracellular delivery platform for immune cells$755,544
R44 · FY2018 · GM
Applications of a robust, vector-free intracellular delivery platform for immune cells$743,988
R44 · FY2017 · GM
A Vector-free Intracellular Delivery Platform for Drug Discovery$652,538
R44 · FY2016 · GM
Tolerance Induction to Prevent Immunity to Viral Gene Therapies$253,055
R43 · FY2019 · AI
Development of a robust, vector-free intracellular delivery platform for immune cells$250,620
R43 · FY2015 · GM
Cell Engineering Platform for Red Blood Cell Mediated Treatment of Autoimmune Diseases$250,000
R43 · FY2018 · EB
Development of a robust, vector-free intracellular delivery platform for immune cells$242,725
R43 · FY2016 · GM
Development of a Vector-free Intracellular Delivery Platform for High Throughput Screening$223,690
R43 · FY2015 · GM
Applications of a robust, vector-free intracellular delivery platform for immune cells$163,570
R44 · FY2018 · GM